Spinal metastases: modern diagnostics, multimodal approach to treatment, and long-term outcomes
Russian Journal of Oncology · 27.12.2025 · 31 (1) · 25-41
DOI: 10.17816/onco697157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Russian Journal of Oncology, online erschienen am 27.12.2025. Verfasst von Anvar F. Nazarov und 5 weiteren Autor:innen. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The review is devoted to a comprehensive analysis of modern aspects of diagnosis, treatment, and outcome prognostication in patients with spinal metastases (SM) . The relevance of the topic stems from the widespread prevalence of this pathology. The work examines the pathogenetic mechanisms of SM development, involving various molecular pathways such as RANK/RANKL/OPG in the process of bone destruction, as well as the clinical picture characterized by pain syndrome, neurological disorders, and a high risk of pathological fractures. Special attention is paid to modern diagnostic methods: positron emission tomography (PET) and single-photon emission computed tomography (SPECT/CT), which are used to detect metastatic disease. The importance of morphological tumor identification using histological methods with core needle biopsy under imaging guidance is noted. The multimodal approach to SM treatment is based on the NOMS framework (Neurologic, Oncologic, Mechanical, Systemic), which combines assessment of neurological impairment, tumor characteristics, mechanical stability of the spinal column (using the SINS scale), and systemic risk factors. SM treatment includes conservative therapy (anti-resorptive drugs and analgesics), stereotactic radiosurgery (SRS/SBRT), minimally invasive surgical methods (vertebroplasty, kyphoplasty), and open surgical methods (separation and decompression-stabilization procedures). A personalized multidisciplinary approach integrating various methods allows effective control of disease progression and improves patients’ quality of life by managing associated pain, correcting neurological deficits, and enabling early mobilization The review also discusses promising directions in targeted therapy, which may become possible through in-depth study of the RSPO2/LGR4 signaling pathway and the application of artificial intelligence technologies to improve the diagnostic accuracy of SM.
Zitieren
APA
Nazarov, A. F., Karaguzin, R. A., Khalilov, D. I., Akhmerov, N. B., Volkova, E. N., & Baiguvatova, K. A. (2025). Spinal metastases: modern diagnostics, multimodal approach to treatment, and long-term outcomes. Russian Journal of Oncology, 31(1), 25-41. https://doi.org/10.17816/onco697157
Vancouver
Nazarov AF, Karaguzin RA, Khalilov DI, Akhmerov NB, Volkova EN, Baiguvatova KA. Spinal metastases: modern diagnostics, multimodal approach to treatment, and long-term outcomes. Russian Journal of Oncology. 2025;31(1):25-41. doi:10.17816/onco697157
BibTeX
@article{Nazarov2025,
author = {Nazarov, Anvar F. and Karaguzin, Rail A. and Khalilov, Danil I. and Akhmerov, Nadir B. and Volkova, Elena N. and Baiguvatova, Kamila A.},
title = {Spinal metastases: modern diagnostics, multimodal approach to treatment, and long-term outcomes},
journal = {Russian Journal of Oncology},
year = {2025},
volume = {31},
number = {1},
pages = {25--41},
doi = {10.17816/onco697157}
}
EUVIMED